Michael P. Bailey
Chief Executive Officer at AVEO PHARMACEUTICALS, INC.
Net worth: - $ as of 2023-12-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brittany Davison | F | - | - | |
| Andrew Hall | M | - | 4 years | |
| Michael Kalos | M | 62 | 3 years | |
| Saman Maleki | M | - | 2 years | |
| Danielle Holland | F | - | - | |
| Kyle Kuvalanka | M | 56 | 3 years | |
| Delphine Davan | F | - | 5 years | |
| Annie Tanguay | F | - | - | |
| Michael Ferraresso | M | - | 7 years | |
| Linda Barabe | F | - | - | |
| Emile Farhan | M | - | 12 years | |
| Markus Warmuth | M | 53 | 6 years | |
| Jaywin Lee | M | - | 1 years | |
| Anisha Wharton | F | - | 3 years | |
| Brent Gardner | M | - | - | |
| Jennifer Schmitke | M | - | - | |
| Jebediah Ledell | M | 49 | 3 years | |
| Jinchul Jeong | M | - | - | |
| Tracy Sherren | F | 58 | - | |
| Ryan Marshall | M | - | 8 years | |
| Stefanie Solomon | F | - | - | |
| Matthew Coulter | M | - | - | |
| Marie-Eve Charrois | F | - | - | |
| David Crist | M | - | 4 years | |
| Stéphane Fiset | M | - | - | |
| Jeremy Graff | M | - | 3 years | |
| Shabnam Kazmi | F | - | 1 years | |
| Kevin Peacock | M | - | - | |
| Michael Smith | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tuan Ha-Ngoc | M | 72 | 13 years | |
| Harlan Waksal | M | 71 |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 21 years |
| Frederic Ors | M | 50 | 6 years | |
| Kenneth E. Weg | M | 85 | 12 years | |
| John Johnson | M | 66 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Gregory Mayes | M | 55 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 11 years |
| Donna M. Radzik | M | - | - | |
| Henri A. Termeer | M | 78 | 6 years | |
| Matthew D. Dallas | M | 49 | 7 years | |
| Ken Bate | M | 73 | 16 years | |
| Samuel D. Waksal | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 18 years |
| John E. Celentano | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Ronald DePinho | M | 69 | 11 years | |
| Suzanne Fleming | F | 63 | 8 years | |
| Wayne Pisano | M | 69 | 10 years | |
| Elan Ezickson | M | 60 | 10 years | |
| Eric W. Jacobson | M | 66 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 4 years |
| Raju S. Kucherlapati | M | 81 | 19 years | |
| Shermaine Tilley | M | 72 | 7 years | |
| Keith S. Ehrlich | M | 73 | 2 years | |
| Corinne Epperly | M | 46 | 2 years | |
| Christine Cvijic | F | 46 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Joseph Vittiglio | M | 52 | 8 years | |
| Philip Frost | M | 84 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Michael N. Needle | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 11 years |
| Scarlett Spring | F | 60 | 4 years | |
| Karuna Rubin | F | 47 | 6 years | |
| Kevin J. Cullen | M | 67 | 2 years | |
| Daniel O'Connor | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Jeno Gyuris | M | 64 | 12 years | |
| Lisa M. Bruneau | F | - | 7 years | |
| Douglas Cole | M | 63 | 10 years | |
| Erik D. Ramanathan | M | 52 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Eric Rowinsky | M | 67 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Jennifer Simpson | M | 55 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Nicholas G. Galakatos | M | 66 | 10 years | |
| Robert C. Young | M | 84 | 12 years | |
| Anthony Evnin | M | 83 | 21 years | |
| Julia Gregory | F | 71 | 5 years | |
| Russell C. Hirsch | M | 62 | 9 years | |
| James Hall | M | 79 | 11 years | |
| Daniel Lynch | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| Robert Epstein | M | 69 | 2 years | |
| QI Bo | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Nikhil Mehta | M | 65 | 2 years | |
| Valerie L. Legagneur | F | 50 | - | |
| Carole Varanelli | F | - | - | |
| Thomas Perone | M | 59 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 5 years |
| Marianne Stanford | M | - | 11 years | |
| Catherine Vaczy | F | 62 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 years |
| Elizabeth Yamashita | F | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 5 years |
| Martin Birkhofer | M | - | - | |
| Catherine DeRose | F | - | 3 years | |
| Michael J. Howerton | M | 72 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 5 years |
| Ana I. Stancic | F | 66 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Albert Dauray | M | - | - | |
| Dan Hicklin | M | 60 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 19 years |
| Joseph L. Fischer | M | 73 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Pierre Labbé | M | 58 | 5 years | |
| Hai Ying He | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Carl Samuel Goldfischer | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Joseph I. DePinto | M | 57 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| William W. Crouse | M | 80 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Thomas F. Deuel | M | 89 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| Jason Kim | M | 49 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 3 years |
| Ian Judson | M | - |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | - |
| Alexander Denner | M | 54 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 2 years |
| Lijun Sun | M | 61 |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | 7 years |
| Andrew Bonfield | M | 61 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 1 years |
| John A. Fazio | M | 80 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 4 years |
| May Han | M | - | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 77 | 77.00% |
| Canada | 23 | 23.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael P. Bailey
- Personal Network
